Your browser doesn't support javascript.
loading
Computer-aided detection of mantle cell lymphoma on 18F-FDG PET/CT using a deep learning convolutional neural network.
Zhou, Zijian; Jain, Preetesh; Lu, Yang; Macapinlac, Homer; Wang, Michael L; Son, Jong Bum; Pagel, Mark D; Xu, Guofan; Ma, Jingfei.
Affiliation
  • Zhou Z; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Jain P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Lu Y; Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Macapinlac H; Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Wang ML; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Son JB; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Pagel MD; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Xu G; Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Ma J; Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
Am J Nucl Med Mol Imaging ; 11(4): 260-270, 2021.
Article in En | MEDLINE | ID: mdl-34513279
ABSTRACT
18F-FDG PET/CT can provide quantitative characterization with prognostic value for mantle cell lymphoma (MCL). However, detection of MCL is performed manually, which is labor intensive and not a part of the routine clinical practice. This study investigates a deep learning convolutional neural network (DLCNN) for computer-aided detection of MCL on 18F-FDG PET/CT. We retrospectively analyzed 142 baseline 18F-FDG PET/CT scans of biopsy-confirmed MCL acquired between May 2007 and October 2018. Of the 142 scans, 110 were from our institution and 32 were from outside institutions. An Xception-based U-Net was constructed to classify each pixel of the PET/CT images as MCL or not. The network was first trained and tested on the within-institution scans by applying five-fold cross-validation. Sensitivity and false positives (FPs) per patient were calculated for network evaluation. The network was then tested on the outside-institution scans, which were excluded from network training. For the 110 within-institution patients (85 male; median age, 58 [range 39-84] years), the network achieved an overall median sensitivity of 88% (interquartile range [IQR] 25%) with 15 (IQR 12) FPs/patient. Sensitivity was dependent on lesion size and SUVmax but not on lesion location. For the 32 outside-institution patients (24 male; median age, 59 [range 40-67] years), the network achieved a median sensitivity of 84% (IQR 24%) with 14 (IQR 10) FPs/patient. No significant performance difference was found between the within and outside institution scans. Therefore, DLCNN can potentially help with MCL detection on 18F-FDG PET/CT with high sensitivity and limited FPs.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Am J Nucl Med Mol Imaging Year: 2021 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Am J Nucl Med Mol Imaging Year: 2021 Document type: Article Affiliation country: United States